Maja Tomić, PhD

Dr sc. Maja Tomić

Position: Full Professor
Organizational unit: Department of Pharmacology
Address: Vojvode Stepe 450, 11221 Belgrade, Serbia
Room: B 305
Telefon: +381 11 3951-374
Fax: +381 11 3972-840
Emailmajat@pharmacy.bg.ac.rs


CV


Maja Tomić (born Malinović) graduated from the Faculty of Pharmacy, University of Belgrade in 1998. She received her master's degree in 2004 and her doctorate in 2008 from the Faculty of Medicine, University of Belgrade, in the field of pharmacology of pain. Since 2000, she has been employed at the Department of Pharmacology, where she went through all the titles from teaching associate to full professor (2020).

She participates in the teaching in integrated academic studies, doctoral academic studies, specialization of health professionals (Pharmacotherapy) and specialist academic studies (Pharmacotherapy in pharmaceutical practice). She was the mentor of one and a member of the commission of 5 defended doctoral dissertations. She has been a mentor or co-mentor on several student research papers. She is currently a member of the commission for monitoring and improving the quality of teaching, the ethics commission for working with experimental animals and working groups for science and the formation of united biomedical laboratory at the Faculty.

She is the co-author of the textbook Pharmacotherapy for Pharmacists and The Practicum in Pharmacology. She is also the co-author of the serbian translation of one pharmacology textbook.

She has published 40 full length, peer reviewed scientific papers in journals from the SCI list. She is the author of a chapter in international monograph. She is also a researcher on a scientific project of the Serbian Science Fund (The IDEAS Program: Fight_PainAndComorb) and institutional funding of the Ministry of Education, Science and Technological Development of the Republic of Serbia. Her research interest includes the effects of atypical analgesics (antiepileptics, antidepressants and others) in animal models of pain, the mechanism of their analgesic action, as well as interactions with other atypical and classical analgesics. During 2016, she trained at the research center of the Medical Faculty of the University of Colorado (Anschutz Medical Campus University of Colorado), as a scholarship holder of The Fulbright Visiting Scholar program, in the field of electrophysiology of neurons involved in pain transmission.

As a lecturer, she participated in more than 20 professional conferences or continuing education courses. She is a member of the Expert Board of the Pharmaceutical Association of Serbia (SFUS) as well as an expert of the Agency for Medicines and Medical Devices of Serbia (ALIMS). She is a reviewer in several international journals and one domestic journal. Also, she is a member of the Pharmaceutical Society of Serbia, the Serbian Pharmacological Society, the Society for Neuroscience of Serbia and the International Association for the Study of Pain (IASP).


  • Micov AM, Tomić MA, Todorović MB, Vuković MJ, Pecikoza UB, Jasnic NI, Djordjevic JD, Stepanović-Petrović RM. Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109975. doi: 10.1016/j.pnpbp.2020.109975.

  • Tomić M, Pecikoza U, Micov A, Vučković S, Stepanović-Petrović R. Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence. Pharmacol Ther. 2018 Dec;192:42-64. doi: 10.1016/j.pharmthera.2018.06.002.

  • Tomić MA, Pecikoza UB, Micov AM, Stepanović-Petrović RM. The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors. Anesth Analg. 2015 Dec;121(6):1632-9. doi: 10.1213/ANE.0000000000000953.

  • Stepanović-Petrović RM, Micov AM, Tomić MA, Kovačević JM, Bošković BD. Antihyperalgesic/antinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents. Anesthesiology. 2014 Mar;120(3):737-50. doi: 10.1097/ALN.0000435833.33515.ba.

  • Tomić MA, Vučković SM, Stepanović-Petrović RM, Ugrešić ND, Prostran MS, Bošković B. Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents. Anesth Analg. 2010 Apr 1;110(4):1198-205. doi: 10.1213/ANE.0b013e3181cbd8da.

  • Micov A, Tomić M, Popović B, Stepanović-Petrović R. The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action. Br J Pharmacol. 2010 Sep;161(2):384-92. doi: 10.1111/j.1476-5381.2010.00877.x.

  • Tomić MA, Vučković SM, Stepanović-Petrović RM, Micov AM, Ugrešić ND, Prostran MS, Bosković B. Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice. Eur J Pharmacol. 2010 Feb 25;628(1-3):75-82. doi: 10.1016/j.ejphar.2009.11.016.

  • Stepanović-Petrović RM, Tomić MA, Vučković SM, Paranos S, Ugrešić ND, Prostran MS, Milovanović S, Bošković B. The antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesth Analg. 2008 Jun;106(6):1897-903. doi: 10.1213/ane.0b013e318172b993.

  • Vučković SM, Tomić MA, Stepanović-Petrović RM, Ugrešić N, Prostran MS, Bošković B. The effects of alpha2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain. 2006 Nov;125(1-2):10-9. doi: 10.1016/j.pain.2006.04.023.

  • Tomić MA, Vučković SM, Stepanović-Petrović RM, Ugrešić N, Prostran MŠ, Bošković B. The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain. 2004 Oct;111(3):253-260. doi: 10.1016/j.pain.2004.07.010.